Melanie Lehman Selected Research

thalicthuberine

1/2018

Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melanie Lehman Research Topics

Disease

8	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2012
7	Neoplasms (Cancer) 01/2022 - 09/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2017
1	Triple Negative Breast Neoplasms 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Obesity 12/2020
1	Hypoadiponectinemia 12/2020

Drug/Important Bio-Agent (IBA)

2	AdipokinesIBA 01/2021 - 12/2020
2	AndrogensIBA 01/2021 - 03/2017
2	Biological ProductsIBA 01/2018 - 01/2017
1	Neuropilin-1IBA 01/2022
1	ClaudinsIBA 01/2022
1	LeptinIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Adiponectin ReceptorsIBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	AdiponectinIBA 12/2020
1	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 12/2020
1	Insulin (Novolin)FDA Link 12/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Antimitotic AgentsIBA 01/2018
1	thalicthuberineIBA 01/2018
1	AlkaloidsIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 10/2014
1	ChitinasesIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	integrin-linked kinaseIBA 12/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 03/2017